GRID Database & Research Tool
Prostate & Bladder Cancer Research
Key Facts
About Decipher Biosciences
Decipher Biosciences, operating as the core urology franchise within Veracyte, Inc., is dedicated to transforming cancer care through genomic diagnostics. The company has achieved significant commercial success and clinical validation with its Decipher Prostate and Decipher Bladder tests, which are now integral tools for risk stratification in prostate and bladder cancer management. Its strategy centers on expanding clinical utility, driving adoption through key guideline inclusion and payer coverage, and leveraging its genomic database to fuel research and development. Decipher aims to solidify its leadership in urologic oncology by continuously generating evidence and exploring new applications for its platform.
View full company profile